CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction

Published:2020-09-15 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Kim Ye-Seul,Zhang Haiying,Lee Sunghye,Park Songyi,Noh Minyoung,Kim Young-Myeong,Kwon Young-Guen

Funder

Ministry of Education

Ministry of Science and Technology

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference43 articles.

1. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice;Agrawal;Oncotarget,2014

2. Angiogenesis in Inflammatory Bowel Disease;Alkim;Int. J. Inflam.,2015

3. Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic;Argollo;Curr. Pharm. Des.,2019

4. Electrolyte and acid-base disorders in inflammatory bowel disease;Barkas;Ann. Gastroenterol.,2013

5. Sac-1004, a Pseudo-Sugar Derivative of Cholesterol, Restores Erectile Function through Reconstruction of Nonleaky and Functional Cavernous Angiogenesis in the Streptozotocin Induced Diabetic Mouse;Batbold;J. Urol.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mexenone protects mice from LPS-induced sepsis by EC barrier stabilization;PLOS ONE;2024-05-09

2. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice;Journal of Pharmacological Sciences;2024-02

3. CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome;Frontiers in Pharmacology;2023-08-30

4. Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury;Cells;2023-05-09

5. Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury;Journal of Inflammation;2023-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3